+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Medicine Market - Global Forecast 2026-2032- Product Image
Personalized Medicine Market - Global Forecast 2026-2032- Product Image
New

Personalized Medicine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977907
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The personalized medicine market is undergoing rapid transformation as healthcare providers, technology firms, and life sciences organizations integrate diagnostics, digital platforms, and targeted therapies to enable data-driven, individualized care strategies.

Personalized Medicine Market Snapshot

The Personalized Medicine Market grew from USD 466.84 billion in 2025 to USD 512.73 billion in 2026 and is projected to reach USD 923.94 billion by 2032, at a CAGR of 10.24%. This expansion reflects intensified investment in genomic sequencing, molecular diagnostics, and innovative therapeutic modalities across the global healthcare landscape.

Scope & Segmentation

  • Product Types: Diagnostics (including companion diagnostics, genetic testing platforms, imaging modalities, molecular assays) and Therapeutics (cell and gene therapies, immunotherapies, monoclonal antibodies, targeted pharmaceuticals).
  • Technology: Bioinformatics tools, digital health platforms, artificial intelligence solutions, genomics, proteomics, and pharmacogenomics applications.
  • Applications: Cardiology (genetic risk profiling, device-integrated diagnostics), endocrinology (hormone receptor assays), infectious diseases (multiplexed diagnostics), neurology (biomarker discovery, pharmacogenomics), oncology (tumor genomic profiling).
  • End Users: Academic research institutes, diagnostic laboratories, hospitals, and clinics.
  • Geographic Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific.

These segmentation criteria enable leaders to assess opportunities across every node of the value chain, from upstream innovation to downstream care delivery.

Key Takeaways

  • Advanced diagnostics paired with tailored therapies are accelerating the shift towards truly individualized patient pathways, minimizing adverse effects and elevating outcomes.
  • AI-driven analytics and integrative platforms support real-time, evidence-based decision-making by synthesizing multi-omic, biometric, and electronic health record data.
  • Regional centers of excellence are driving momentum, while cross-border consortiums and public-private partnerships are critical for scaling access to precision interventions.
  • Regulatory frameworks now reward clinical utility, robust evidence generation, and iterative development, encouraging agile approaches to market entry.
  • Strategic collaborations between pharmaceutical giants, biotechs, and digital health providers are producing end-to-end solutions, from discovery to clinical deployment.
  • Niche innovators focusing on rare disease and behavioral health integrations are extending personalized medicine’s reach to new patient populations.

Tariff Impact on Supply Chain and Collaboration

Recent U.S. tariff policies, implemented in 2025, are altering procurement dynamics for diagnostic reagents, sequencing consumables, and biologics materials. To manage increased costs and delivery risks, many organizations are diversifying suppliers, adopting near-shoring strategies, and building regional manufacturing capabilities. Strategic partnerships now increasingly include proactive risk management and flexible supply chain models to maintain access to precision medicine solutions.

Methodology & Data Sources

This assessment employs a combination of primary and secondary research. Qualitative input from industry leaders, clinical experts, and regulatory authorities is complemented by survey feedback gathered from diagnostic laboratories, hospitals, and research institutions. Secondary research draws from scientific literature, regulatory filings, patent databases, and corporate disclosures. Data are triangulated and cross-validated for consistency and reliability, underpinning every insight included in this report.

Why This Report Matters

  • Enables strategic decision-making by mapping evolving technologies, supply chain risks, and regulatory trends shaping the personalized medicine market.
  • Offers actionable segmentation insights to help target product development, investment, and go-to-market strategies across disease areas and regions.
  • Equips leaders with evidence-backed forecasts and qualitative perspectives that support competitive positioning and long-term planning.

Conclusion

The convergence of advanced diagnostics, digital platforms, and interdisciplinary collaboration is setting new industry standards in personalized medicine. Stakeholders committed to improving patient outcomes and care efficiencies will find enduring opportunities by adapting to this market’s dynamic, data-driven paradigm.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Personalized Medicine Market, by Product Type
8.1. Diagnostics
8.1.1. Companion Diagnostics
8.1.2. Genetic Testing
8.1.3. Imaging Diagnostics
8.1.4. Molecular Diagnostics
8.2. Therapeutics
8.2.1. Cell & Gene Therapy
8.2.2. Immunotherapy
8.2.3. Monoclonal Antibodies
8.2.4. Pharmaceuticals
9. Personalized Medicine Market, by Technology
9.1. Bioinformatics
9.2. Digital Health & AI
9.3. Genomics & Proteomics
9.4. Pharmacogenomics
10. Personalized Medicine Market, by Application
10.1. Cardiology
10.1.1. Arrhythmia
10.1.2. Heart Failure
10.2. Endocrinology
10.3. Infectious Diseases
10.3.1. Bacterial
10.3.2. Viral
10.4. Neurology
10.4.1. Neurodegenerative
10.4.2. Psychiatric
10.5. Oncology
10.5.1. Hematologic Malignancies
10.5.2. Solid Tumors
11. Personalized Medicine Market, by End User
11.1. Academic & Research Institutes
11.2. Diagnostic Laboratories
11.3. Hospitals & Clinics
12. Personalized Medicine Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Personalized Medicine Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Personalized Medicine Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Personalized Medicine Market
16. China Personalized Medicine Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Agilent Technologies, Inc.
17.7. AMGEN INC
17.8. BGI Genomics Co., Ltd.
17.9. Bio-Rad Laboratories, Inc.
17.10. Biogen Inc
17.11. Bio-Techne Corporation
17.12. bluebird bio, Inc.
17.13. CRISPR Therapeutics AG
17.14. Danaher Corporation
17.15. Exact Sciences Corporation
17.16. GE Healthcare Technologies, Inc
17.17. Guardant Health, Inc.
17.18. Illumina, Inc.
17.19. Myriad Genetics, Inc.
17.20. Novartis AG
17.21. Pfizer Inc
17.22. PierianDx, Inc.
17.23. QIAGEN N.V.
17.24. Roche Holding AG
17.25. Siemens Healthcare GmbH
17.26. Thermo Fisher Scientific Inc.
17.27. Vertex Pharmaceuticals Incorporated
List of Figures
FIGURE 1. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PERSONALIZED MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CELL & GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CELL & GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIGITAL HEALTH & AI, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIGITAL HEALTH & AI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIGITAL HEALTH & AI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMICS & PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMICS & PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ARRHYTHMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ARRHYTHMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEURODEGENERATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEURODEGENERATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEURODEGENERATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 155. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 177. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 178. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 195. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 196. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 200. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 201. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. GCC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GCC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. GCC PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 206. GCC PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 207. GCC PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. GCC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. GCC PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 210. GCC PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 211. GCC PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 212. GCC PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 213. GCC PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 228. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 229. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 232. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 233. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 234. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 235. BRICS PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. G7 PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. G7 PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. G7 PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 239. G7 PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 240. G7 PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. G7 PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. G7 PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 243. G7 PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 244. G7 PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 245. G7 PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 246. G7 PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. NATO PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. NATO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. NATO PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 250. NATO PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 251. NATO PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. NATO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. NATO PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 254. NATO PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 255. NATO PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 256. NATO PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 257. NATO PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. CHINA PERSONALIZED MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 271. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 273. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 274. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 277. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 278. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 279. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 280. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Personalized Medicine market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AMGEN INC
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biogen Inc
  • Bio‑Techne Corporation
  • bluebird bio, Inc.
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Exact Sciences Corporation
  • GE Healthcare Technologies, Inc
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Novartis AG
  • Pfizer Inc
  • PierianDx, Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 512.73 Billion
Forecasted Market Value ( USD ) by 2032 $ 923.94 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Personalized Medicine Market Report 2025 - Product Image

Personalized Medicine Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Personalized Medicine Market - Types, Technologies and Applications - Product Image

Personalized Medicine Market - Types, Technologies and Applications

  • Report
  • 341 Pages
  • Global
From
Personalized Medicine Market Companies Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts - Product Image

Personalized Medicine Market Companies Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts

  • Report
  • 200 Pages
  • Global
From
Personalized Medicine Bioinformatics Market Report 2025 - Product Image

Personalized Medicine Bioinformatics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Personalized Medicine Biomarkers - Global Strategic Business Report - Product Image

Personalized Medicine Biomarkers - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From

About the Personalized Medicine Market

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.